Bio-Techne TECH Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's operating cash flow?
- Bio-Techne (TECH) reported operating cash flow of $86.66M in Q1 2026.
- How has Bio-Techne's operating cash flow changed year-over-year?
- Bio-Techne's operating cash flow increased by 110.8% year-over-year, from $41.12M to $86.66M.
- What is the long-term trend for Bio-Techne's operating cash flow?
- Over 4 years (2021 to 2025), Bio-Techne's operating cash flow has grown at a -4.9% compound annual growth rate (CAGR), from $352.16M to $287.56M.
- What does operating cash flow mean?
- The total amount of cash generated by the company's day-to-day business operations.
- How do you interpret operating cash flow?
- An increase indicates stronger operational performance and better cash-generating capability.
- How does operating cash flow compare across companies?
- The standard benchmark for operational health across all public companies.